These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 6283409)
1. Attenuation of hypertension by conjugation estrogens. Elias AN; Meshkinpour H; Valenta LJ Nephron; 1982; 30(1):89-92. PubMed ID: 6283409 [TBL] [Abstract][Full Text] [Related]
2. Estrogens and hypertension: effect of discontinuing estrogens on blood pressure, exchangeable sodium, and the renin-aldosterone system. Crane MG; Harris JJ Am J Med Sci; 1978; 276(1):33-55. PubMed ID: 45830 [No Abstract] [Full Text] [Related]
3. Inhibition of PG synthesis by indomethacin does not influence the exercise induced stimulation of renin-angiotensin-aldosterone system in hypertensives treated with captopril. Novo S; Adamo L; Nardi E; Licata G; Strano A Prog Clin Biol Res; 1987; 242():387-92. PubMed ID: 3313416 [No Abstract] [Full Text] [Related]
4. Dihydrospirorenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin-aldosterone system in normal women. Oelkers W; Berger V; Bolik A; Bähr V; Hazard B; Beier S; Elger W; Heithecker A J Clin Endocrinol Metab; 1991 Oct; 73(4):837-42. PubMed ID: 1890155 [TBL] [Abstract][Full Text] [Related]
5. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. Smith NL; Heckbert SR; Lemaitre RN; Reiner AP; Lumley T; Weiss NS; Larson EB; Rosendaal FR; Psaty BM JAMA; 2004 Oct; 292(13):1581-7. PubMed ID: 15467060 [TBL] [Abstract][Full Text] [Related]
6. Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension. New MI; Levine LS; Biglieri EG; Pareira J; Ulick S J Clin Endocrinol Metab; 1977 May; 44(5):924-33. PubMed ID: 870517 [TBL] [Abstract][Full Text] [Related]
7. Mineralocorticoid hypertension in childhood. New MI; Levine LS Mayo Clin Proc; 1977 May; 52(5):323-8. PubMed ID: 323586 [TBL] [Abstract][Full Text] [Related]
8. Study of the effects of cicletanine on the renin-angiotensin-aldosterone system. Bippi H; Guinot P Drugs Exp Clin Res; 1988; 14(2-3):215-20. PubMed ID: 3046885 [TBL] [Abstract][Full Text] [Related]
9. Influence of dietary sodium on the renin-angiotensin-aldosterone system and prevalence of left ventricular hypertrophy by EKG criteria. Williams JS; Williams GH; Jeunemaitre X; Hopkins PN; Conlin PR J Hum Hypertens; 2005 Feb; 19(2):133-8. PubMed ID: 15361890 [TBL] [Abstract][Full Text] [Related]
10. [Effect of combined use of pindolol and clopamide on the renin-angiotensin-aldosterone system, electrolyte metabolism and kidney function in patients with primary arterial hypertension]. Wyrzykowski B; Suchecka-Rachoń K Pol Arch Med Wewn; 1987; 77(1-2):31-9. PubMed ID: 3079500 [No Abstract] [Full Text] [Related]
11. [Sodium outflow rate through lymphocyte cell membranes, serum levels of sodium, potassium, aldosterone, total catecholamines, 6-keto- PGF2alpha and plasma renin activity in patients with primary arterial hypertension treated with captopril]. Mazurek W; Halawa B; Borejko-Słopecka G Pol Tyg Lek; 1992 Jul 6-13; 47(27-28):588-93. PubMed ID: 1488334 [TBL] [Abstract][Full Text] [Related]
12. Central vasopressor responses to conjugated estrogens in rats may be mediated via a renin-angiotensin system in the brain. Takahashi H; Ashizawa H; Takeda KU; Yoneda S; Yoshimura M; Ijichi H J Pharmacol Exp Ther; 1982 Sep; 222(3):726-30. PubMed ID: 6286934 [TBL] [Abstract][Full Text] [Related]
13. Effects of magnesium on the renin-angiotensin-aldosterone system in human subjects. Ichihara A; Suzuki H; Saruta T J Lab Clin Med; 1993 Oct; 122(4):432-40. PubMed ID: 8228558 [TBL] [Abstract][Full Text] [Related]
14. Effect of enalapril on renin, angiotensin converting enzyme activity, aldosterone and prostaglandins in patients with hypertension. Larochelle P; Gutkowska J; Schiffrin E; Kuchel O; Hamet P; Genest J Clin Invest Med; 1985; 8(3):197-201. PubMed ID: 2994932 [TBL] [Abstract][Full Text] [Related]
15. Lack of effect of captopril on the sodium retention of the nephrotic syndrome. Brown EA; Markandu ND; Sagnella GA; Jones BE; MacGregor GA Nephron; 1984; 37(1):43-8. PubMed ID: 6371561 [TBL] [Abstract][Full Text] [Related]
16. Relationship between vasopressin and the renin-angiotensin-aldosterone system in essential hypertension: effect of converting enzyme inhibitor on plasma vasopressin. Santucci A; Leonetti Luparini R; Ferri C; Ficara C; Giarrizzo C; Balsano F J Hypertens Suppl; 1985 Nov; 3(2):S133-4. PubMed ID: 3003302 [TBL] [Abstract][Full Text] [Related]
17. Relationship between urinary sodium excretion and serum aldosterone in patients with diabetes in the presence and absence of modifiers of the renin-angiotensin-aldosterone system. Libianto R; Jerums G; Lam Q; Chen A; Baqar S; Pyrlis F; Macisaac RJ; Moran J; Ekinci EI Clin Sci (Lond); 2014 Jan; 126(2):147-54. PubMed ID: 23875766 [TBL] [Abstract][Full Text] [Related]
19. [The effect of long-term treatment of arterial hypertension with Ca antagonists on the renin-angiotensin-aldosterone system in diabetics. Hyporeninemic hypoaldosteronism]. Hrnciar J; Jakubíková K; Hrnciarová M; Kreze A; Chamulová M Vnitr Lek; 1995 Oct; 41(10):661-6. PubMed ID: 8578695 [TBL] [Abstract][Full Text] [Related]
20. The effect of conjugated estrogens on the renin-angiotensin system. Pallas KG; Holzwarth GJ; Stern MP; Lucas CP J Clin Endocrinol Metab; 1977 Jun; 44(6):1061-8. PubMed ID: 194909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]